1. Home
  2. PMVP vs ARMP Comparison

PMVP vs ARMP Comparison

Compare PMVP & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMVP
  • ARMP
  • Stock Information
  • Founded
  • PMVP 2013
  • ARMP N/A
  • Country
  • PMVP United States
  • ARMP United States
  • Employees
  • PMVP N/A
  • ARMP N/A
  • Industry
  • PMVP Medicinal Chemicals and Botanical Products
  • ARMP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PMVP Health Care
  • ARMP Health Care
  • Exchange
  • PMVP Nasdaq
  • ARMP Nasdaq
  • Market Cap
  • PMVP 85.5M
  • ARMP 80.0M
  • IPO Year
  • PMVP 2020
  • ARMP N/A
  • Fundamental
  • Price
  • PMVP $1.40
  • ARMP $1.97
  • Analyst Decision
  • PMVP Strong Buy
  • ARMP Strong Buy
  • Analyst Count
  • PMVP 3
  • ARMP 1
  • Target Price
  • PMVP $5.33
  • ARMP $7.00
  • AVG Volume (30 Days)
  • PMVP 142.5K
  • ARMP 6.9K
  • Earning Date
  • PMVP 02-27-2025
  • ARMP 03-20-2025
  • Dividend Yield
  • PMVP N/A
  • ARMP N/A
  • EPS Growth
  • PMVP N/A
  • ARMP N/A
  • EPS
  • PMVP N/A
  • ARMP N/A
  • Revenue
  • PMVP N/A
  • ARMP $5,467,000.00
  • Revenue This Year
  • PMVP N/A
  • ARMP $23.87
  • Revenue Next Year
  • PMVP N/A
  • ARMP N/A
  • P/E Ratio
  • PMVP N/A
  • ARMP N/A
  • Revenue Growth
  • PMVP N/A
  • ARMP 34.92
  • 52 Week Low
  • PMVP $1.32
  • ARMP $1.80
  • 52 Week High
  • PMVP $2.26
  • ARMP $4.48
  • Technical
  • Relative Strength Index (RSI)
  • PMVP 47.66
  • ARMP 43.35
  • Support Level
  • PMVP $1.37
  • ARMP $1.97
  • Resistance Level
  • PMVP $1.46
  • ARMP $2.22
  • Average True Range (ATR)
  • PMVP 0.05
  • ARMP 0.10
  • MACD
  • PMVP 0.01
  • ARMP -0.01
  • Stochastic Oscillator
  • PMVP 78.57
  • ARMP 2.50

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: